Hallek Interview Part 3: Clinical Trials in CLL

Creative Commons License

Transcript of Hallek Interview Part 3: Clinical Trials in CLL

Created Date: July 07, 2009

Description: Dr. Michael Hallek discusses the benefits and challenges of using mouse models such as TCL1, NOD/SCID, and NZB in CLL drug trials and studies attempting to isolate potential cancer stem cells. Then, he discusses proposed trials comparing the effectiveness of various drug combinations and, hypothetically, how one might develop a study to determine whether certain types of chemical agents are linked to CLL.

Creator: Gerald Marti

Contributor: Michael Hallek

Identifier: Hallek03_research

Subject: Clinical Research, Treatment

Related: Hallek01_collaboration, Hallek02_treatment

Series: Hallek Oral Histories

Type: Video

Rights: This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

%d bloggers like this: